SI-BONE, Inc. (SIBN) News
Filter SIBN News Items
SIBN News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest SIBN News From Around the Web
Below are the latest news stories about SI-BONE INC that investors may wish to consider to help them evaluate SIBN as an investment opportunity.
Si-Bone (SIBN) Crossed Above the 50-Day Moving Average: What That Means for InvestorsShould investors be excited or worried when a stock crosses above the 50-Day simple moving average? |
Insider Sell: President, Commercial Ops Anthony Recupero Sells 8,457 Shares of SI-BONE Inc (SIBN)In a recent transaction on November 17, 2023, Anthony Recupero, President of Commercial Operations at SI-BONE Inc, sold 8,457 shares of the company's stock. |
SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023SANTA CLARA, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Piper Sandler Healthcare Conference in New York. Management will be hosting a fireside chat on Tuesday, November 28, 2023, at 3:30 p.m. Eastern Time / 12:30 p.m. Pacific Time. Investors interested in listening to the conference call may do so b |
SI-BONE, Inc. (NASDAQ:SIBN) Q3 2023 Earnings Call TranscriptSI-BONE, Inc. (NASDAQ:SIBN) Q3 2023 Earnings Call Transcript November 6, 2023 Operator: Good afternoon and welcome to SI-BONE’s Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. We will be facilitating a question and answer session towards the end of today’s call. As a reminder, this call is being […] |
Q3 2023 SI-BONE Inc Earnings CallQ3 2023 SI-BONE Inc Earnings Call |
SI-BONE Inc (SIBN) Reports Record Q3 2023 Financial Results, Raises Annual GuidanceRevenue growth of 29% and gross margin of 79% highlight the quarter's performance |
SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual GuidanceAnnual guidance increased to $136 million - $137 million, implying annual growth of 28%-29%SANTA CLARA, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended September 30, 2023. Recent Financial Highlights Record worldwide revenue of $34.0 million for the third quarter 2023, representing approximately 29% growth over the corre |
The past three years for SI-BONE (NASDAQ:SIBN) investors has not been profitableMany investors define successful investing as beating the market average over the long term. But its virtually certain... |
SI-BONE To Present at Jefferies London Healthcare Conference on November 15, 2023SANTA CLARA, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Jefferies London Healthcare Conference in London, UK. Management will be hosting a fireside chat on Wednesday, November 15, 2023, at 4:00 a.m. Eastern Time / 1:00 a.m. Pacific Time. Investors interested in listening to the conference call may d |
SI-BONE to Report Third Quarter 2023 Financial Results on November 6, 2023SANTA CLARA, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the third quarter of 2023 after market close on Monday, November 6, 2023. Management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by reg |